title: Rates of aldosterone antagonist use after myocardial infarction remain poor over time among guideline eligible patients.
authors.affiliation: Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
authors.forename: Houman
authors.initials: H
authors.lastname: Khalili
authors.affiliation: Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
authors.forename: Anthony
authors.initials: A
authors.lastname: Edwards
authors.affiliation: Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Jones
authors.affiliation: Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
authors.forename: James A
authors.initials: JA
authors.lastname: de Lemos
authors.affiliation: Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, United States. Electronic address: Sandeep.das@utsouthwestern.edu.
authors.forename: Sandeep R
authors.initials: SR
authors.lastname: Das
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000188:drug therapy*; D017410:Practice Guidelines as Topic / Q000592:standards; D013997:Time Factors
chemical_list: D000451:Mineralocorticoid Receptor Antagonists
keywords: ACS; Aldosterone antagonist; Guideline adherence; Guidelines; Myocardial infarction; Quality improvement